Dr. Mark Geraci

The Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado Denver consists of over 100 faculty located in six hospitals and two research institutes. These include University of Colorado Hospital, Denver Veterans Administration Hospital, Denver Health Medical Center, National Jewish Medical and Research Center, Columbia Rose Medical Center, and Centura Health/St. Anthony’s Medical Center. Faculty are located at all of these sites as well as the Webb-Waring Research Institute and the Cardiovascular Pulmonary Research Laboratory. The overall Division headed by Mark Geraci, MD. The faculty, clinical programs and research programs at the various sites are fully integrated.

The fellowship, which graduates six trainees each year, is a three-year program. The majority of the trainees, however, remain for additional years for further research training. The research training of the fellows is supported by an NHLBI training grant, which just started its 26st consecutive year of funding. There have been 180 graduates of this program and at present 120 are active in academic medicine and medical scientific investigation. This includes over 50 professors and 10 Division heads. The training of pulmonary and critical care medicine fellows for careers in academic medicine, along with patient care and medical scientific investigation, remain the major thrusts of the Division.

The very productive faculty is responsible for the publication of over 400 scholarly peer-reviewed papers yearly as well as many monographs, books, editorials and invited reviews. They are also the recipients of numerous research grants, primarily from the National Institutes of Health. This includes specialized centers of research and program project grants in Acute Lung Injury, Interstitial Lung Disease, Asthma, Acute Lung Injury, Adaptation to Hypoxia, Cystic Fibrosis, Beryllium related disease, Pulmonary Hypertension, and Lipids, Eicosanoids and Lung Cell Physiology. Divisional investigators are also involved in the Cancer Center's lung cancer grants. Three centers for the clinical study of Asthma, Acute Lung Injury, and Lung Reduction Surgery were awarded to investigators in the division by the National Health, Lung, and Blood Institute to Divisional faculty. Moreover, multiple individual grants are supported by federal, private and industry sources.

Specialized centers of clinical and investigative excellence have been established in Pulmonary hypertension (Drs. Norbert Voelkel and David Badesch), Adult Cystic Fibrosis and Genetic Lung Disease (Dr. Jerry Nick), Lung Transplantation and Lung Reduction (Dr. Martin Zamora), and Acute Lung Injury and Sepsis Interventional Trials (Dr. Edward Abraham), and Emphysema (Dr. Norbert Voelkel) all based at University of Colorado Hospital. The Centers for Interstitial Lung Disease (Dr. Kevin Brown, Dr. Marvin Schwarz), Asthma (Dr. Richard Martin), Occupational Lung Disease (Drs. Cecil Rose and Lisa Maier), and Sarcoidosis (Dr. Cecil Rose) are centered at National Jewish Center for Immunology and Respiratory Medicine. The Lung Cancer Center’s clinical activities are based at Denver Veterans Administration Hospital and the University of Colorado Hospital(Drs York Miller and Robert Keith).